IRVINE, Calif. and IRVING, Texas, Sept. 3,
2014 /PRNewswire/ -- Novation and Edwards Lifesciences
Corporation (NYSE: EW) today announced they have entered into a
three-year, sole-source strategic relationship that provides the
world's market leading heart valve therapies to the more than
100,000 members and affiliates of VHA, UHC, Children's Hospital
Association and Provista.
The new agreement with Edwards for its heart valve product
portfolio enables Novation to enter the heart valve category for
the first time, and expands on the previous relationship between
the companies for critical care technologies.
"This heart valve agreement enables Novation to provide marked
additional value to hospitals and their patients with Edwards
Lifesciences' clinically proven, life-saving heart valve devices,"
said David Richman, vice president,
Sourcing Operations, Novation. "We are proud that Edwards
believes in Novation's unique capabilities and we look forward to
working with them to deliver value to the members we serve."
More than 100,000 heart valve procedures are performed in
the United States every
year. There are more than 750 hospital facilities purchasing
products via Novation contracts to perform heart valve surgeries
and interventions.
"Edwards invests significantly in the development of new
treatment options that can provide meaningful benefits to patients,
and we look forward to working in partnership with Novation so that
heart valve patients can get the treatments they need from Edwards'
comprehensive valve portfolio," said Donald
E. Bobo, Jr., Edwards' corporate vice president, heart valve
therapy.
Novation awards product agreements to suppliers by using
member-driven criteria and a weighted award decision tool that
considers product specification, quality and patient safety, as
well as financial factors. This comprehensive competitive
contracting process involves clinicians from participating member
organizations to the greatest practical degree and follows
established principles of the American Bar Association's Model
Procurement Code.
About Novation, Winner of the Ethics Inside®
Certification
Founded in 1998, Novation is a leading health care services
company for the more than 100,000 members and affiliates of VHA
Inc. and UHC, two national health care alliances, Children's
Hospital Association, an alliance of the nation's leading pediatric
facilities, and Provista, LLC. Novation provides alliance members
with sourcing services, as well as information and data services.
Based in Irving, Texas, Novation
develops and manages competitive contracts with more than 700
suppliers. Members of VHA, UHC, Children's Hospital Association and
Provista used Novation contracts to purchase approximately
$49 billion in 2013. Novation has
earned the coveted Ethics Inside Certification from Ethisphere
Institute, a leading international think tank dedicated to the
research and promotion of best practices in corporate ethics and
compliance. Novation was also named on Ethisphere's World's Most
Ethical Companies list, and is the only company in the health care
industry to earn both distinctions for three consecutive years. To
learn more about Novation, please follow @NovationNews.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring, enabling them to save and enhance
lives. Additional company information can be found at
www.edwards.com.
SOURCE Novation